BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37191369)

  • 1. SUMO1 degrader induces ER stress and ROS accumulation through deSUMOylation of TCF4 and inhibition of its transcription of StarD7 in colon cancer.
    Zhao YQ; Jin HR; Kim D; Jung SH; Liu S; Wan J; Lo HY; Fu XQ; Wang Q; Hao C; Bellail AC
    Mol Carcinog; 2023 Sep; 62(9):1249-1262. PubMed ID: 37191369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors.
    Bellail AC; Jin HR; Lo HY; Jung SH; Hamdouchi C; Kim D; Higgins RK; Blanck M; le Sage C; Cross BCS; Li J; Mosley AL; Wijeratne AB; Jiang W; Ghosh M; Zhao YQ; Hauck PM; Shekhar A; Hao C
    Sci Transl Med; 2021 Oct; 13(615):eabh1486. PubMed ID: 34644148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of StarD7 promotes endoplasmic reticulum stress and induces ROS production.
    Flores-Martín J; Reyna L; Ridano ME; Panzetta-Dutari GM; Genti-Raimondi S
    Free Radic Biol Med; 2016 Oct; 99():286-295. PubMed ID: 27554972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases.
    Pandey D; Chen F; Patel A; Wang CY; Dimitropoulou C; Patel VS; Rudic RD; Stepp DW; Fulton DJ
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1634-42. PubMed ID: 21527745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO1 attenuates stress-induced ROS generation by inhibiting NADPH oxidase 2.
    Kim HJ; Yun J; Lee J; Hong H; Jeong J; Kim E; Bae YS; Lee KJ
    Biochem Biophys Res Commun; 2011 Jul; 410(3):555-62. PubMed ID: 21683690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells.
    Rena V; Angeletti S; Panzetta-Dutari G; Genti-Raimondi S
    Placenta; 2009 Oct; 30(10):876-83. PubMed ID: 19679347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer.
    Zhou F; Gao H; Shang L; Li J; Zhang M; Wang S; Li R; Ye L; Yang S
    J Exp Clin Cancer Res; 2023 Jun; 42(1):150. PubMed ID: 37337284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription.
    Chhunchha B; Fatma N; Kubo E; Singh DP
    FEBS J; 2014 Aug; 281(15):3357-81. PubMed ID: 24910119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the lipid transport protein StarD7 in mitochondrial dynamics.
    Rojas ML; Cruz Del Puerto MM; Flores-Martín J; Racca AC; Kourdova LT; Miranda AL; Panzetta-Dutari GM; Genti-Raimondi S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Dec; 1866(12):159029. PubMed ID: 34416390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. StarD7 gene expression in trophoblast cells: contribution of SF-1 and Wnt-beta-catenin signaling.
    Rena V; Flores-Martín J; Angeletti S; Panzetta-Dutari GM; Genti-Raimondi S
    Mol Endocrinol; 2011 Aug; 25(8):1364-75. PubMed ID: 21622533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO1/UBC9‑decreased Nox1 activity inhibits reactive oxygen species generation and apoptosis in diabetic retinopathy.
    Hu J; Xue P; Mao X; Xie L; Li G; You Z
    Mol Med Rep; 2018 Jan; 17(1):1690-1698. PubMed ID: 29138839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levistolide A Induces Apoptosis via ROS-Mediated ER Stress Pathway in Colon Cancer Cells.
    Yang Y; Zhang Y; Wang L; Lee S
    Cell Physiol Biochem; 2017; 42(3):929-938. PubMed ID: 28662507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
    Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
    Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
    Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
    Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells.
    Celesia A; Morana O; Fiore T; Pellerito C; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Calvaruso G; Giuliano M; Emanuele S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells.
    Banerjee A; Banerjee V; Czinn S; Blanchard T
    Oncotarget; 2017 Apr; 8(16):26142-26153. PubMed ID: 28412728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis.
    Yuan H; Deng R; Zhao X; Chen R; Hou G; Zhang H; Wang Y; Xu M; Jiang B; Yu J
    Mol Cancer; 2017 Oct; 16(1):157. PubMed ID: 29020972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
    Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
    Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mode of action of NKP-1339 - a clinically investigated ruthenium-based drug - involves ER- and ROS-related effects in colon carcinoma cell lines.
    Flocke LS; Trondl R; Jakupec MA; Keppler BK
    Invest New Drugs; 2016 Jun; 34(3):261-8. PubMed ID: 26988975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer.
    Hong H; Cao W; Wang Q; Liu C; Huang C
    Med Oncol; 2022 May; 39(5):101. PubMed ID: 35599281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.